Mapping of Signaling Pathways Linked to sIgAD Reveals Impaired IL-21 Driven STAT3 B-Cell Activation.
dc.contributor.author | Lemarquis, Andri L | |
dc.contributor.author | Theodors, Fannar | |
dc.contributor.author | Einarsdottir, Helga K | |
dc.contributor.author | Ludviksson, Bjorn R | |
dc.date.accessioned | 2019-05-21T11:31:58Z | |
dc.date.available | 2019-05-21T11:31:58Z | |
dc.date.issued | 2019-03 | |
dc.date.submitted | 2019-05 | |
dc.identifier.citation | Mapping of Signaling Pathways Linked to sIgAD Reveals Impaired IL-21 Driven STAT3 B-Cell Activation. 2019, 10:403 Front Immunol | en_US |
dc.identifier.issn | 1664-3224 | |
dc.identifier.pmid | 30936864 | |
dc.identifier.doi | 10.3389/fimmu.2019.00403 | |
dc.identifier.uri | http://hdl.handle.net/2336/620911 | |
dc.description | To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Download | en_US |
dc.description.abstract | Objectives: It has recently been shown that individuals with selective IgA deficiency (sIgAD) have defective B cell responses both to T cell dependent and independent mimicking stimulations. The complex intracellular signaling pathways from different stimuli leading to IgA isotype switching have not been fully elucidated. Thus, the main objective of this study was to delineate these pathways and their potential role in the immunopathology linked to sIgAD. Materials and Methods: PBMCs from 10 individuals with sIgAD and 10 healthy controls (HC) were activated in vitro via either a T cell dependent or independent mimicking stimulation. Intracellular phosphorylation of pSTAT3, pSTAT5, pSTAT6, and as pERK1/2 was evaluated in T and B cells using phosphoflow cytometry. Results: By evaluating T cell dependent cytokine driven pathways linked to IgA isotype induction we identified a defect involving an IL-21 driven STAT3 activation isolated to B cells in sIgAD individuals. However, all other signaling pathways studied were found to be normal compared to HC. In T cell dependent cytokine driven stimulations linked to IgA isotype induction the following patterns emerged: (i) IL-10 led to significant STAT3 activation in both T- and B cells; (ii) IL-4 stimulation was predominantly confined to STAT6 activation in both T- and B cells, with some effects on STAT3 activation in T-cells; (iii) as expected, of tested stimuli, IL-2 alone activated STAT5 and some STAT3 activation though in both cases only in T-cells; (iv) IL-21 induced significant activation of STAT3 in both T- and B cells, with some effects on STAT5 activation in T-cells; and finally (v) synergistic effects were noted of IL-4+IL-10 on STAT5 activation in T-cells, and possibly STAT6 in both T- and B cells. On the other hand, CPG induced T cell independent activation was confined to ERK1/2 activation in B cells. Conclusion: Our results indicate a diminished STAT3 phosphorylation following IL-21 stimulation solely in B cells from sIgAD individuals. This can represent aberrant germinal center reactions or developmental halt. Thus, our work provides further insight into the unraveling of the previously hypothesized role of IL-21 to reconstitute immunoglobulin production in primary antibody deficiencies. | en_US |
dc.description.sponsorship | Icelandic Research Fund University hospital of Iceland research fund | en_US |
dc.language.iso | en | en_US |
dc.publisher | Frontiers Research Foundation | en_US |
dc.relation.url | https://www.frontiersin.org/articles/10.3389/fimmu.2019.00403/full | en_US |
dc.subject | B cells | en_US |
dc.subject | IL-21 | en_US |
dc.subject | IgA | en_US |
dc.subject | T cells | en_US |
dc.subject | pSTAT3 | en_US |
dc.subject | phosphoflow | en_US |
dc.subject | selective IgA deficiency | en_US |
dc.subject | Ónæmisfræði | en_US |
dc.subject.mesh | IgA Deficiency | en_US |
dc.title | Mapping of Signaling Pathways Linked to sIgAD Reveals Impaired IL-21 Driven STAT3 B-Cell Activation. | en_US |
dc.type | Article | en_US |
dc.contributor.department | 1 Department of Immunology, Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland. 2 Faculty of Medicine, University of Iceland, Reykjavík, Iceland. | en_US |
dc.identifier.journal | Frontiers in immunology | en_US |
dc.rights.access | Open Access - Opinn aðgangur | en_US |
dc.departmentcode | AAI12 | |
dc.source.journaltitle | Frontiers in immunology | |
refterms.dateFOA | 2019-05-21T11:32:00Z |